Literature DB >> 9491860

Lymphatic spread in stage Ib and II cervical carcinoma: anatomy and surgical implications.

G Michel1, P Morice, D Castaigne, M Leblanc, A Rey, P Duvillard.   

Abstract

OBJECTIVE: To determine the frequency and topography of pelvic and para-aortic node involvement in cervical carcinoma and to identify the appropriate level for resection of the lymphatic chains.
METHODS: Between 1985 and 1994, 421 women with stage Ib or II cervical carcinoma were treated by surgery in combination with irradiation. Each underwent a radical hysterectomy with systematic pelvic and para-aortic lymphadenectomy.
RESULTS: A median of 34 lymph nodes were removed per patient. The overall frequency of lymph node involvement was 26%, and the frequency of para-aortic metastases was 8%. The frequency of lymph node metastasis was associated significantly with stage (chi(2) = 7.8; P < .02), tumor size (chi(2) = 14.8; P < .001), and patient age (chi(2) = 5.9; P < .05). The frequency of para-aortic involvement was below 3% in patients with small tumors (under 2 cm). When pelvic nodes were involved, the obturator group was concerned in 76 cases (18%) and the external iliac group in 48 patients (11%). When para-aortic nodes were involved, the left para-aortic chain was the most frequently concerned (23 patients [5%]). In eight of these patients, nodal involvement was found only above the level of the inferior mesenteric artery. Among 106 patients with pelvic positive nodes, 28 (26%) also had para-aortic metastatic nodes.
CONCLUSION: Para-aortic lymphadenectomy should remove all of the left para-aortic chain (inframesenteric and supramesenteric) and so should be performed up to the level of the left renal vein. According to the low frequency of para-aortic involvement when tumor size is below 2 cm, such a procedure could be avoided in patients with small tumors.

Entities:  

Mesh:

Year:  1998        PMID: 9491860     DOI: 10.1016/s0029-7844(97)00696-0

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  24 in total

Review 1.  Up-to-date management of lymph node metastasis and the role of tailored lymphadenectomy in cervical cancer.

Authors:  Noriaki Sakuragi
Journal:  Int J Clin Oncol       Date:  2007-06-27       Impact factor: 3.402

2.  Node-by-node correlation between MR and PET/CT in patients with uterine cervical cancer: diffusion-weighted imaging versus size-based criteria on T2WI.

Authors:  Eugene K Choi; Jeong Kon Kim; Hyuck Jae Choi; Seong Ho Park; Bum-Woo Park; Namkug Kim; Jae Seung Kim; Ki Chun Im; Gyunggoo Cho; Kyoung-Sik Cho
Journal:  Eur Radiol       Date:  2009-03-11       Impact factor: 5.315

3.  Single-port laparoscopy and extraperitoneal para-aortic lymphadenectomy for locally advanced cervical cancer: assessment after 52 consecutive patients.

Authors:  Sébastien Gouy; Catherine Uzan; Stéphanie Scherier; Tristan Gauthier; Enrica Bentivegna; Aminata Kane; Philippe Morice; Frédéric Marchal
Journal:  Surg Endosc       Date:  2013-09-06       Impact factor: 4.584

4.  Differentiating metastatic from nonmetastatic lymph nodes in cervical cancer patients using monoexponential, biexponential, and stretched exponential diffusion-weighted MR imaging.

Authors:  Qingxia Wu; Dandan Zheng; Ligang Shi; Mingbo Liu; Meiyun Wang; Dapeng Shi
Journal:  Eur Radiol       Date:  2017-05-22       Impact factor: 5.315

5.  Anatomic location of PET-positive aortocaval nodes in patients with locally advanced cervical cancer: implications for surgical staging.

Authors:  Michael Frumovitz; Pedro T Ramirez; Homer A Macapinlac; Ann H Klopp; Alpa M Nick; Lois M Ramondetta; Anuja Jhingran
Journal:  Int J Gynecol Cancer       Date:  2012-09       Impact factor: 3.437

Review 6.  Analysis of morbidity and clinical implications of laparoscopic para-aortic lymphadenectomy in a continuous series of 98 patients with advanced-stage cervical cancer and negative PET-CT imaging in the para-aortic area.

Authors:  Catherine Uzan; Amine Souadka; Sebastien Gouy; Thierry Debaere; Juliette Duclos; Jean Lumbroso; Christine Haie-Meder; Philippe Morice
Journal:  Oncologist       Date:  2011-06-09

7.  Prognostic factors and morbidities after completion surgery in patients undergoing initial chemoradiation therapy for locally advanced cervical cancer.

Authors:  Cyril Touboul; Catherine Uzan; Audrey Mauguen; Sebastien Gouy; Annie Rey; Patricia Pautier; Catherine Lhommé; Pierre Duvillard; Christine Haie-Meder; Philippe Morice
Journal:  Oncologist       Date:  2010-03-23

8.  Results of the GYNECO 02 study, an FNCLCC phase III trial comparing hysterectomy with no hysterectomy in patients with a (clinical and radiological) complete response after chemoradiation therapy for stage IB2 or II cervical cancer.

Authors:  Philippe Morice; Philippe Rouanet; Annie Rey; Pascale Romestaing; Gilles Houvenaeghel; Jean Charles Boulanger; Jean Leveque; Didier Cowen; Patrice Mathevet; Jean Pierre Malhaire; Guillaume Magnin; Eric Fondrinier; Jocelyne Berille; Christine Haie-Meder
Journal:  Oncologist       Date:  2012-01-10

9.  Sentinel node detection with (99m)Tc phytate alone is satisfactory for cervical cancer patients undergoing radical hysterectomy and pelvic lymphadenectomy.

Authors:  Shinji Ogawa; Hiroaki Kobayashi; Satoshi Amada; Hideaki Yahata; Kenzo Sonoda; Koichiro Abe; Shingo Baba; Masayuki Sasaki; Tsunehisa Kaku; Norio Wake
Journal:  Int J Clin Oncol       Date:  2010-01-21       Impact factor: 3.402

10.  Differing prognosis of cervical cancer patients with high risk of treatment failure after radical hysterectomy warrants trial treatment modification.

Authors:  Woo-Young Kim; Suk-Joon Chang; Ki-Hong Chang; Seung-Chul Yoo; Mison Chun; Hee-Sug Ryu
Journal:  J Gynecol Oncol       Date:  2009-03-31       Impact factor: 4.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.